Arabic Arabic English English French French German German
dark

Cancer immunotherapy gets PIP boost

A synthetic molecular code shows promise towards improving the response of some cancer patients to immunotherapy treatments. The approach involves using a molecule that can provide energy to anti-cancer immune cells, increasing their numbers and improving their longevity. The findings were published by Kyoto University scientists, led by Hiroshi Sugiyama, in the journal Cell Chemical Biology. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

UK OKs vaccines for 12 year olds, aims to avoid lockdowns

Next Post

Socio-economic status of children can influence microorganisms in their digestive tract

Related Posts
Total
0
Share